309 related articles for article (PubMed ID: 9748559)
1. Binding sites for exogenous and endogenous non-competitive inhibitors of the nicotinic acetylcholine receptor.
Arias HR
Biochim Biophys Acta; 1998 Aug; 1376(2):173-220. PubMed ID: 9748559
[TBL] [Abstract][Full Text] [Related]
2. Topology of ligand binding sites on the nicotinic acetylcholine receptor.
Arias HR
Brain Res Brain Res Rev; 1997 Oct; 25(2):133-91. PubMed ID: 9403137
[TBL] [Abstract][Full Text] [Related]
3. Noncompetitive inhibition of nicotinic acetylcholine receptors by endogenous molecules.
Arias HR
J Neurosci Res; 1998 May; 52(4):369-79. PubMed ID: 9589382
[TBL] [Abstract][Full Text] [Related]
4. Luminal and non-luminal non-competitive inhibitor binding sites on the nicotinic acetylcholine receptor.
Arias HR
Mol Membr Biol; 1996; 13(1):1-17. PubMed ID: 9147657
[TBL] [Abstract][Full Text] [Related]
5. 5-Doxylstearate-induced displacement of phencyclidine from its low-affinity binding sites on the nicotinic acetylcholine receptor.
Arias HR
Arch Biochem Biophys; 1999 Nov; 371(1):89-97. PubMed ID: 10525293
[TBL] [Abstract][Full Text] [Related]
6. Agonist self-inhibitory binding site of the nicotinic acetylcholine receptor.
Arias HR
J Neurosci Res; 1996 Apr; 44(2):97-105. PubMed ID: 8723217
[TBL] [Abstract][Full Text] [Related]
7. The high-affinity quinacrine binding site is located at a non-annular lipid domain of the nicotinic acetylcholine receptor.
Arias HR
Biochim Biophys Acta; 1997 Jul; 1347(1):9-22. PubMed ID: 9233683
[TBL] [Abstract][Full Text] [Related]
8. Localization of agonist and competitive antagonist binding sites on nicotinic acetylcholine receptors.
Arias HR
Neurochem Int; 2000 Jun; 36(7):595-645. PubMed ID: 10771117
[TBL] [Abstract][Full Text] [Related]
9. Role of local anesthetics on both cholinergic and serotonergic ionotropic receptors.
Arias HR
Neurosci Biobehav Rev; 1999; 23(6):817-43. PubMed ID: 10541058
[TBL] [Abstract][Full Text] [Related]
10. Quinacrine and ethidium bromide bind the same locus on the nicotinic acetylcholine receptor from Torpedo californica.
Lurtz MM; Hareland ML; Pedersen SE
Biochemistry; 1997 Feb; 36(8):2068-75. PubMed ID: 9047305
[TBL] [Abstract][Full Text] [Related]
11. Interaction of lipids and ligands with nicotinic acetylcholine receptor vesicles assessed by electron paramagnetic resonance spectroscopy.
Arias HR
Methods Mol Biol; 2010; 606():291-318. PubMed ID: 20013404
[TBL] [Abstract][Full Text] [Related]
12. Agonist-induced displacement of quinacrine from its binding site on the nicotinic acetylcholine receptor: plausible agonist membrane partitioning mechanism.
Arias HR
Mol Membr Biol; 1995; 12(4):339-47. PubMed ID: 8747279
[TBL] [Abstract][Full Text] [Related]
13. Positive and negative modulation of nicotinic receptors.
Arias HR
Adv Protein Chem Struct Biol; 2010; 80():153-203. PubMed ID: 21109220
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the dizocilpine binding site on the nicotinic acetylcholine receptor.
Arias HR; McCardy EA; Blanton MP
Mol Pharmacol; 2001 May; 59(5):1051-60. PubMed ID: 11306687
[TBL] [Abstract][Full Text] [Related]
15. Temperature and ionic strength dependence of quinacrine binding and quinacrine displacement elicited by high concentrations of agonists on the nicotinic acetylcholine receptor.
Arias HR
Arch Biochem Biophys; 1996 Sep; 333(1):1-11. PubMed ID: 8806747
[TBL] [Abstract][Full Text] [Related]
16. Noncompetitive antagonist binding sites in the torpedo nicotinic acetylcholine receptor ion channel. Structure-activity relationship studies using adamantane derivatives.
Arias HR; Trudell JR; Bayer EZ; Hester B; McCardy EA; Blanton MP
Biochemistry; 2003 Jun; 42(24):7358-70. PubMed ID: 12809491
[TBL] [Abstract][Full Text] [Related]
17. The steroid promegestone is a noncompetitive antagonist of the Torpedo nicotinic acetylcholine receptor that interacts with the lipid-protein interface.
Blanton MP; Xie Y; Dangott LJ; Cohen JB
Mol Pharmacol; 1999 Feb; 55(2):269-78. PubMed ID: 9927618
[TBL] [Abstract][Full Text] [Related]
18. Examining the noncompetitive antagonist-binding site in the ion channel of the nicotinic acetylcholine receptor in the resting state.
Blanton MP; McCardy EA; Gallagher MJ
J Biol Chem; 2000 Feb; 275(5):3469-78. PubMed ID: 10652341
[TBL] [Abstract][Full Text] [Related]
19. Regulation of ligand-gated ion channels by protein phosphorylation.
Swope SL; Moss SJ; Raymond LA; Huganir RL
Adv Second Messenger Phosphoprotein Res; 1999; 33():49-78. PubMed ID: 10218114
[TBL] [Abstract][Full Text] [Related]
20. (-)-Reboxetine inhibits muscle nicotinic acetylcholine receptors by interacting with luminal and non-luminal sites.
Arias HR; Ortells MO; Feuerbach D
Neurochem Int; 2013 Nov; 63(5):423-31. PubMed ID: 23917086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
